Postoperative Pain Management in Patients Undergoing Intramedullary Nail Fixation After Tibia and Femoral Fractures
Femur Fracture, Tibial Fractures
About this trial
This is an interventional treatment trial for Femur Fracture focused on measuring Opioid use, Post-operative pain, Analgesic use, Femur fracture, Tibia fracture, Intramedullary Nailing
Eligibility Criteria
Inclusion Criteria:
- Patients with tibial and femoral shaft fractures
- Patients undergoing intramedullary nailing
- Willing to participate in the protocol
Exclusion Criteria:
- Chronic pain disorder (daily use of oral opioids)
- Allergy or hypersensitivity to non steroid anti-inflammatory drug
- Impaired renal, cardiac, or hepatic function
- History of gastrointestinal bleeding or substance abuse
Sites / Locations
- University District Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group 1: Intravenous Ketorolac and oral acetaminophen
Group 2: Intravenous Morphine and oral oxycodone
Group 1 will be composed of patients receiving the following standard pain control protocol: ketorolac 30 mg intravenous (IV) every 6 hours for patients younger than 70 years versus ketorolac 15 mg IV every 6 hours for patients older than 70 years, first dose will be administered 30 minutes preoperatively. An additional 1000mg of oral acetaminophen will be administered every 6 hours simultaneously regardless of the age group. Patients who determine pain to be unbearable and wish to opt out of the non-opioid group will receive may do so.
Group 2 will be composed of patients receiving the following pain control protocol: morphine 0.1 mg per kg intravenous every 6 hours with an additional oral oxycodone combined with acetaminophen 2 tabs every 6 hours.